The global burden of gastric cancer increasing, predominantly in developing countries | | *1 | A |
| | | |
H pylori infection is the most common proven risk factor for human non-cardiac gastric cancer | | | A |
| | | |
The risk for gastric cancer development depends on bacterial virulence factors | | | A |
| | | |
The risk for gastric cancer development depends on host genetic factors | | | B |
| | | |
Environmental factors contribute to the risk of gastric cancer | | | A |
| | | |
Evidence for H pylori as an important factor for gastric cancer development is shown by experimental animal models | | | B |
| | | |
Eradication of H pylori prevents development of pre-neoplastic changes of the gastric mucosa | | 1b | A |
| | | |
Eradication of H pylori has the potential to reduce the risk of gastric cancer development | | 1c | B |
| | | |
The optimal time to eradicate H pylori is before pre-neoplastic conditions (atrophy, intestinal metaplasia) are present, probably in early adulthood | | 1b | A |
| | | |
H pylori eradication for gastric cancer prevention is cost effective in economic analyses. Feasibility studies are required to evaluate further the benefits and risks of this strategy | | *2 | B |
| | | |
The potential for gastric cancer prevention on a global scale is restricted by currently available treatments | | 1b | A |
| | | |
New treatments are required for a global strategy of eradication to prevent gastric cancer | | | A |
| | | |
H pylori eradication for gastric cancer prevention in populations at risk should he evaluated and considered | | 2a | B |